(NYSE: STE) Steris's forecast annual revenue growth rate of 6.93% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Steris's revenue in 2026 is $5,935,900,000.On average, 12 Wall Street analysts forecast STE's revenue for 2027 to be $628,071,990,975, with the lowest STE revenue forecast at $604,452,189,605, and the highest STE revenue forecast at $655,303,084,290. On average, 12 Wall Street analysts forecast STE's revenue for 2028 to be $667,796,202,370, with the lowest STE revenue forecast at $637,051,419,595, and the highest STE revenue forecast at $698,052,972,720.
In 2029, STE is forecast to generate $708,691,643,585 in revenue, with the lowest revenue forecast at $687,219,096,885 and the highest revenue forecast at $737,386,774,175.